Acute exacerbation of psoriasis after COVID-19 Pfizer vaccination.

Autor: Lopez ED; Department of Internal Medicine, University of New Mexico Health Sciences Center, Albuquerque, New Mexico., Javed N; Department of Internal Medicine, Shifa International Hospital, Islamabad, Pakistan., Upadhyay S; Department of Internal Medicine, University of New Mexico Health Sciences Center, Albuquerque, New Mexico., Shekhar R; Division of Hospital Medicine, Department of Internal Medicine, University of New Mexico School of Medicine, Albuquerque, New Mexico., Sheikh AB; Department of Internal Medicine, University of New Mexico Health Sciences Center, Albuquerque, New Mexico.
Jazyk: angličtina
Zdroj: Proceedings (Baylor University. Medical Center) [Proc (Bayl Univ Med Cent)] 2021 Nov 15; Vol. 35 (2), pp. 199-201. Date of Electronic Publication: 2021 Nov 15 (Print Publication: 2022).
DOI: 10.1080/08998280.2021.2003681
Abstrakt: The novel coronavirus (COVID-19) pandemic has caused many deaths worldwide. Managing and diagnosing dermatological conditions has become difficult during this era, especially with the widespread administration of vaccines. We report a 58-year-old man with a history of psoriasis and multiple comorbidities who presented with a worsening pruritic rash 1 week after receiving the COVID-19 Pfizer vaccine. He was treated with triamcinolone-based wet wraps, triamcinolone ointment, and hydroxyzine, which improved his rash significantly after 6 days of hospitalization.
(Copyright © 2021 Baylor University Medical Center.)
Databáze: MEDLINE